Search research articles
Contact Us
Filters
Showing results (441-450 of 527) with videos related to
Page
of 53
Sort By:
Cancer Medicine
|
November 17, 2021
Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels
Po-Yao Hsu, Tzu-Sheng Cheng, Shih-Chang Chuang, et al.
Nature Communications
|
August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection
Atish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.
Clinical and Molecular Hepatology
|
October 4, 2023
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases
Pin-Nan Cheng, Wen-Jone Chen, Charles Jia-Yin Hou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 6, 2021
A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease
Zobair M Younossi, Janus P Ong, Hirokazu Takahashi, et al.
The Lancet. Gastroenterology & Hepatology
|
February 6, 2025
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial
Young-Suk Lim, Ming-Lung Yu, Jonggi Choi, et al.
Gut
|
June 4, 2025
Differential HCC risk among HBV indeterminate types at baseline and by phase transition
Rui Huang, Huy N Trinh, Satoshi Yasuda, et al.
Scientific Reports
|
April 21, 2021
Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan
Ming-Ying Lu, Chun-Ting Chen, Yu-Lueng Shih, et al.
Hepatology Communications
|
January 13, 2021
Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular Carcinoma
Vincent L Chen, Ming-Lun Yeh, Ju Dong Yang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 12, 2021
Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry
Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, et al.
The Journal of Infectious Diseases
|
May 17, 2021
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
Yao-Chun Hsu, Ming-Lun Yeh, Grace Lai-Hung Wong, et al.
Page
of 53
Search research articles
Search
Showing results (441-450 of 527) with videos related to
Sort By:
Page
of 53
Cancer Medicine
|
November 17, 2021
Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels
Po-Yao Hsu, Tzu-Sheng Cheng, Shih-Chang Chuang, et al.
Nature Communications
|
August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection
Atish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.
Clinical and Molecular Hepatology
|
October 4, 2023
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases
Pin-Nan Cheng, Wen-Jone Chen, Charles Jia-Yin Hou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 6, 2021
A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease
Zobair M Younossi, Janus P Ong, Hirokazu Takahashi, et al.
The Lancet. Gastroenterology & Hepatology
|
February 6, 2025
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial
Young-Suk Lim, Ming-Lung Yu, Jonggi Choi, et al.
Gut
|
June 4, 2025
Differential HCC risk among HBV indeterminate types at baseline and by phase transition
Rui Huang, Huy N Trinh, Satoshi Yasuda, et al.
Scientific Reports
|
April 21, 2021
Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan
Ming-Ying Lu, Chun-Ting Chen, Yu-Lueng Shih, et al.
Hepatology Communications
|
January 13, 2021
Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular Carcinoma
Vincent L Chen, Ming-Lun Yeh, Ju Dong Yang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 12, 2021
Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry
Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, et al.
The Journal of Infectious Diseases
|
May 17, 2021
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
Yao-Chun Hsu, Ming-Lun Yeh, Grace Lai-Hung Wong, et al.
Page
of 53